Filing Details
- Accession Number:
- 0001415889-23-000734
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-10 16:57:04
- Reporting Period:
- 2023-01-09
- Accepted Time:
- 2023-01-10 16:57:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1733294 | Generation Bio Co. | GBIO | Pharmaceutical Preparations (2834) | 814301281 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1946316 | Phillip Samayoa | C/O Generation Bio Co. 301 Binney Street, Suite 401 Cambridge MA 02142 | Chief Strategy Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-01-09 | 1,865 | $5.11 | 95,819 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2022.
- Includes 1,865 shares acquired under the company's employee stock purchase plan since October 15, 2022.
Billionaire Hedge Funds
